1. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. (24th July 2013) Authors: Gamaletsou, M. N.; Walsh, T. J.; Zaoutis, T.; Pagoni, M.; Kotsopoulou, M.; Voulgarelis, M.; Panayiotidis, P.; Vassilakopoulos, T.; Angelopoulou, M. K.; Marangos, M.; Spyridonidis, A.; Kofteridis, D.; Pouli, A.; Sotiropoulos, D.; Matsouka, P.; Argyropoulou, A.; Perloretzou, S.; Leckerman, K.; Mana... Journal: Clinical microbiology and infection Issue: Volume 20:Number 1(2014:Jan.) Page Start: O50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenalidomide Induces Responses in Patients with MDS-DEL(5)Q Alone, or with One Additional Abnormality, Irrespective of Who Classification and Prognostic Categorization. (April 2017) Authors: Symeonidis, A.; Kouraklis-Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Zikos, P.; Vassilakopoulos, T.; Pappa, V.; Kotsianidis, I.; Dimou, M.; Palla, K.; Viniou, N.A.; Kartasis, Z.; Pontikoglou, C.; Barbarousi, D.; Pagoni, M.; Xanthopoulidis, G.; Kotsopoulou, M.; Michali, E.; Katodritou, E.... Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P916: COEXISTENCE OF ≥2 HIGH-RISK MOLECULAR ABNORMALITIES SUPERVENES THE PROGNOSTIC VALUE OF THE REVISED INTERNATIONAL STAGING SYSTEM FOR MYELOMA: REAL-WORLD DATA ANALYSIS FROM THE GREEK MYELOMA STUDY GROUP. (23rd June 2022) Authors: Katodritou, E.; Dalampira, D.; Triantafyllou, T.; Gavriatopoulou, M.; Delimpasi, S.; Pouli, A.; Papadopoulou, T.; Verrou, E.; Sevastoudi, A.; Tsirou, K.; Katsika, L.; Douganiotis, G.; Karampatzakis, N.; Metallinou, T.-E.; Palaska, V.; Kotsopoulou, M.; Lalayianni, C.; Kyrtsonis, M.-C.; Spanoudakis... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 806 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT). (12th June 2019) Authors: Vassilakopoulos, T.P.; Papageorgiou, S.G.; Michail, M.; Angelopoulou, M.K.; Kourti, G.; Kalpadakis, C.; Kotsopoulou, M.; Leonidopoulou, T.; Konstantinidou, P.; Kotsianidis, I.; Boutsis, D.; Michali, E.; Sachanas, S.; Terpos, E.; Karianakis, G.; Poziopoulos, C.; Vadikolia, C.; Pigaditou, A.; Vraki... Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: NOVEL PREDICTIVE INDICATORS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH 5-AZACYTIDINE: CUMULATIVE DATA FROM THE HELLENIC MDS STUDY GROUP. (May 2023) Authors: Kotsianidis, I.; Hatzimichael, E.; Pappa, V.; Galanopoulos, A.; Kourakli, A.; Diamantopoulos, P.; Papageorgiou, S.; Liapis, K.; Papadopoulos, V.; Papoutselis, M.; Bouchla, A.; Georgoulis, V.; Vassilakopoulos, T.; Solomou, E.; Dimou, M.; Vassilopoulos, G.; Vardi, A.; Papaioannou, M.; Pontikoglou, ... Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗